Dr. Madis Metsis
CEO of EdiLabs | Molecular Biologist
Driving scientific innovation at the intersection of biotechnology and global health.
Learn More
About Madis
Dr. Madis Metsis is a distinguished molecular biologist with a substantial academic background, having conducted groundbreaking research at the prestigious Karolinska Institutet and The Scripps Research Institute. With over 120 peer-reviewed publications and more than 8,500 citations, his work has significantly influenced the field of molecular biology.
Throughout his career, Dr. Metsis has secured over €1.2 million in research and development funding, supporting innovative projects that bridge the gap between fundamental science and practical applications. His expertise spans multiple areas of molecular biology, now with a particular focus on plant-based therapeutic development.
During the COVID-19 pandemic, Dr Metsis became a trusted voice in Estonia's public health conversation. Commissioned by Postimees, one of the country's largest newspapers, he wrote several in-depth articles to explain new developments, such as vaccines, diagnostic tools and emerging variants, in lay language. His contributions helped make complex scientific topics understandable to the broader public during a time of uncertainty.
As the founder and CEO of EdiLabs, Dr. Metsis leads a team dedicated to revolutionising therapeutic delivery through plant-based biotechnology, applying his extensive knowledge to create solutions that are both scientifically sound and globally accessible.
Scientific Vision
At the core of Dr. Metsis's research philosophy is the belief that therapeutic innovations should be safe, scalable, and globally accessible. Through his work at EdiLabs and collaborations with research institutions worldwide, he is pioneering approaches that leverage the natural capabilities of plants as bioreactors for therapeutic compounds.
"My mission is to help science do more, not just in the lab, but for the world. True innovation comes when we make complex solutions simple, safe, and scalable."
Dr. Metsis envisions a future where plant-based biotechnology plays a central role in addressing global health challenges. By utilising plants as production systems, his research aims to overcome traditional barriers to therapeutic development, including high production costs, complex manufacturing requirements, and limited global distribution.
This vision is guided by rigorous scientific principles, ethical considerations, and a commitment to developing solutions that can benefit populations worldwide, regardless of geographic or economic constraints.
Reimagining How We Deliver Future Medicines
EdiLabs is a biotechnology company focused on developing safe, scalable, and patient-friendly health solutions using plant-based expression systems.
Under Madis's leadership, the company has developed a strong scientific and operational foundation, collaborating with global experts and institutions to bring breakthrough ideas to life.
Current work includes:
- Plant-based expression systems for therapeutic development
- Strategic collaborations with global biotech leaders (incl. Canada, Finland, UK)
- Data-driven innovation across biology, genetics, and health tech
Recognition
- Author of 120+ peer-reviewed publications in molecular biology and biotechnology
- Research cited over 8,500 times by scientists worldwide
- H-index of 42, placing in the top percentile of molecular biology researchers
- Recipient of €1.2M+ in competitive research grants and fellowships
- Invited speaker at 30+ international scientific conferences
- Google Scholar Profile
Contact
If you're interested in discussing scientific collaboration, speaking engagements, or other professional inquiries, please feel free to reach out.